BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37303292)

  • 1. Combination Therapy With CD147-Targeted Nanoparticles Carrying Phenformin Decreases Lung Cancer Growth.
    Pereira-Nunes A; Ferreira H; Abreu S; Guedes M; Neves NM; Baltazar F; Granja S
    Adv Biol (Weinh); 2023 Jul; 7(7):e2300080. PubMed ID: 37303292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
    Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
    Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
    Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
    Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance.
    Kim S; Im JH; Kim WK; Choi YJ; Lee JY; Kim SK; Kim SJ; Kwon SW; Kang KW
    Oxid Med Cell Longev; 2021; 2021():5428364. PubMed ID: 34367462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.
    Wang J; Xia S; Zhu Z
    Cell Biochem Biophys; 2015 Mar; 71(2):513-8. PubMed ID: 25312480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export.
    Li J; Wu Z; Chen G; Wang X; Zhu X; Zhang Y; Zhang R; Wu W; Zhu Y; Ma L; Yu H
    Phytomedicine; 2023 Jan; 109():154618. PubMed ID: 36610137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catastrophic ATP loss underlies a metabolic combination therapy tailored for
    Dalton KM; Lochmann TL; Floros KV; Calbert ML; Kurupi R; Stein GT; McClanaghan J; Murchie E; Egan RK; Greninger P; Dozmorov M; Ramamoorthy S; Puchalapalli M; Hu B; Shock L; Koblinski J; Glod J; Boikos SA; Benes CH; Faber AC
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33762304
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer.
    Park JH; Kim YH; Park EH; Lee SJ; Kim H; Kim A; Lee SB; Shim S; Jang H; Myung JK; Park S; Lee SJ; Kim MJ
    Cancer Sci; 2019 Sep; 110(9):2834-2845. PubMed ID: 31278880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codelivery of dual drugs from polymeric micelles for simultaneous targeting of both cancer cells and cancer stem cells.
    Krishnamurthy S; Ng VW; Gao S; Tan MH; Hedrick JL; Yang YY
    Nanomedicine (Lond); 2015; 10(18):2819-32. PubMed ID: 26377155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance.
    Zeng HZ; Qu YQ; Liang AB; Deng AM; Zhang WJ; Xiu B; Wang H; Wang H
    Neoplasma; 2011; 58(5):449-54. PubMed ID: 21745000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR.
    Veiga SR; Ge X; Mercer CA; Hernández-Álvarez MI; Thomas HE; Hernandez-Losa J; Ramón Y Cajal S; Zorzano A; Thomas G; Kozma SC
    Clin Cancer Res; 2018 Aug; 24(15):3767-3780. PubMed ID: 29691292
    [No Abstract]   [Full Text] [Related]  

  • 13. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
    Shackelford DB; Abt E; Gerken L; Vasquez DS; Seki A; Leblanc M; Wei L; Fishbein MC; Czernin J; Mischel PS; Shaw RJ
    Cancer Cell; 2013 Feb; 23(2):143-58. PubMed ID: 23352126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenformin-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivo.
    Krishnamurthy S; Ng VW; Gao S; Tan MH; Yang YY
    Biomaterials; 2014 Nov; 35(33):9177-86. PubMed ID: 25106770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring metabolic reprogramming in melanoma via acquired resistance to the oxidative phosphorylation inhibitor phenformin.
    Pistoni M; Tondelli G; Gallo C; Torricelli F; Maresca A; Carelli V; Ciarrocchi A; Dallaglio K
    Melanoma Res; 2020 Feb; 30(1):1-13. PubMed ID: 31116160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment.
    Yang H; Zou W; Chen B
    Cell Biol Int; 2013 Oct; 37(10):1139-42. PubMed ID: 23686717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3.
    Lea MA; Guzman Y; Desbordes C
    Anticancer Res; 2016 Apr; 36(4):1479-88. PubMed ID: 27069123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming.
    Kendrick AA; Schafer J; Dzieciatkowska M; Nemkov T; D'Alessandro A; Neelakantan D; Ford HL; Pearson CG; Weekes CD; Hansen KC; Eisenmesser EZ
    Oncotarget; 2017 Jan; 8(4):6742-6762. PubMed ID: 28039486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
    Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
    Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acidosis associated with phenformin therapy. Evidence that inhibited lactate oxidation is the causative factor.
    Searle GL; Siperstein MD
    Diabetes; 1975 Aug; 24(8):741-5. PubMed ID: 1158038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.